Search results
Heart disease: Millions may no longer get preventive statin therapy
Medical News Today· 3 days agoAtherosclerotic cardiovascular disease is linked to plaque buildup in blood vessels. It can increase...
New approach to measuring 'healthy microbiomes' in nature and the gut
Medical Xpress· 9 hours agoThe international study compares case studies of type 2 diabetes, atherosclerotic cardiovascular disease, anxious-depressive behaviors ...
Heart disease: Moderate intake of choline may help reduce risk
Medical News Today· 5 days agoCholine is a nutrient essential for heart health and brain function and is found in many foods like...
New Analysis Finds Millions of People on Statins May Not Need Them
Healthline via AOL· 6 days agocardiovascular disease.” This includes equations like PCE and PREVENT. New analysis may be more...
Chronic high blood pressure during pregnancy doubled between 2008 and 2021 in the US: Study
Medical Xpress· 17 hours agoChronic hypertension in pregnancy is defined as high blood pressure diagnosed before pregnancy or...
Data shows new heart health guidelines could dramatically reduce statin eligibility
McKnight’s Senior Living· 7 days agoHeart Association guidelines passed in November 2023 are widely adopted, about 40% fewer people...
New Cholesterol Guidelines Could Drastically Reduce Statin Use for Millions
SciTechDaily· 21 hours agoIf national guidelines were updated to include a new risk equation, approximately 40% fewer individuals may qualify for cholesterol-lowering statins to prevent heart disease
Man died at Tacoma immigration detention center of natural causes, medical examiner says
The Olympian via Yahoo News· 6 days agoCharles Leo Daniel, a citizen of Trinidad and Tobago, died March 7 of hypertensive and ...
The Shifting Epidemiology of Hypercholesterolemia
MedPage Today· 5 days agoThe epidemiology of hypercholesterolemia has been shifting in recent years. The optimal total cholesterol level is defined as about 150 mg/dL, putting low-density lipoprotein (LDL) cholesterol ...
Ventyx Biosciences stock holds at Neutral amid competitor's trial results By Investing.com
Investing.com· 5 days agoThis drug is seen as a direct rival to Ventyx's own NLRP3 inhibitor, VTX3232. NodThera's NT-0796...